Rocket Pharma (RCKT)
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and sell...
- Open
- 3.540
- High
- 3.810
- Low
- 3.536
- Prev. Close
- 3.530
- Volume
- 2.20M
- Turnover
- 8.24M
- Avg Price
- 3.742
- Bid/Ask Ratio
- --
- Amplitude
- 7.76%
- 52wk High
- 5.450
- Volume Ratio
- 1.70
- Turnover Ratio
- 2.52%
Rocket Pharma Analyst Rating
View moreForecast & Rating
Aug 14, 2026Price forecast
$8.84133.89%
Forecast & RatingBuy
14analysts
- Strong buy42.86%
- Buy0.00%
- Hold42.86%
- Sell7.14%
- Strong sell7.14%
News
- Market Beat · Aug 17 at 06:23 PM
Insider Selling: Rocket Pharmaceuticals (NASDAQ:RCKT) General Counsel Sells $11,806.34 in Stock
- Market Beat · Aug 17 at 12:06 AM
Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded by Wall Street Zen to "Hold" Rating
- Market Beat · Aug 13 at 04:22 PM
Insider Selling: Rocket Pharmaceuticals (NASDAQ:RCKT) Insider Sells $16,453.50 in Stock
- Simplywall · Aug 4 at 06:18 AM
Alto Ingredients And 2 Other Promising Penny Stocks
- StockTitan · Aug 2 at 10:00 PM
Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease | RCKT Stock News
- Market Beat · Aug 1 at 12:48 AM
Rocket Pharmaceuticals (NASDAQ:RCKT) Raised to Hold at Wall Street Zen
